NEW YORK - The chief executive of NuVasive Inc., a medical-device company, exercised options for and sold 20,000 shares of common stock, according to a Securities and Exchange Commission filing Monday.
| NUVA | 48.25 |
In a Form 4 filed with the SEC, Alexis V. Lukianov reported exercising options Friday at $3.75 apiece and selling the shares the same day for $33.96 apiece.
The stock sale was conducted under a prearranged 10b5-1 trading plan which allows company insiders to set up a program in advance for such transactions and proceed even if they come into possession of material nonpublic information.
Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.
NuVasive is based in San Diego.

Gold Gold has flatlined and is marginally higher this morning with the dollar marginally lower and oil marginally higher on continuing concern...
After presenting together at the MTV Movie Awards, Robert Pattinson, Kristen Ste...
A group of suspected drug users arrested in Denver this weekend with methampheta...


Professional Website Design For Corporate - Get a Free Quote Today